Our Services

CAPS offers a comprehensive range of consultation and advisory services to assist with your endeavors in the emergent and dynamic industries of psychedelic-assisted therapies and medical cannabis prescribing in the UK. Explore our services to discover how CAPS can be your trusted partner on the transformative journey within the evolving realm of psychedelic research and therapy.

General advice on psychedelic pharmacology

Psychedelic drugs, such as psilocybin, DMT, LSD, ketamine and MDMA, possess unique psychopharmacological actions, that when combined with focused psychotherapy in a controlled clinical setting, provide an opportunity for more effective, faster, and safe therapy for patents with a range of different psychiatric indications, including depression, anxiety, PTSD, eating disorders and addictions.

1/5

CAPS can provide expert advice and education about the mechanisms of psychedelic drugs, and how they are harnessed in a clinical setting to provide efficacious and safe treatments for patients with psychiatric disorders.

For healthcare professionals establishing clinical services

Numerous physicians, counselors, clinical psychologists, pharmacists, and team managers express an interest in venturing into clinical psychedelic services. However, many find themselves without the requisite expertise and understanding of such an emergent field. CAPS offers comprehensive consultation and advice services to individuals and teams seeking guidance on the intricacies of entering this domain. Our expertise covers a range of issues to facilitate a smooth and informed entry into the field.

Examples of some areas we can assist with are below:

The instigation of a “Clinic in a Box” model
Custom-made, bespoke designed - and implemented into whatever the existing clinic or team requires.
Practical advice for potential stakeholders on how to set up a clinic
How to write psychedelic therapy treatment protocols
How to write SOPs to cover all aspects of your clinic's needs
How to build a multidisciplinary team
How to work with pharmacists/drug supply networks
How to choose appropriate data measurement tools
How to log data onto the national register
Advice around indemnity and legal issues
Advice around documentation / managerial / administration support.
Provide ongoing pharmacovigilance/quality assurance support
Continued risk management strategies
Personalised clinic-based training
Provide annual appraisals / annual certification of quality
Continued CPD activities/training for clinic staff.
Providing doctors about the process of prescribing medical cannabis.

For Investors

Drawing upon two decades of expertise within the psychedelic clinical and research domains, Dr. Sessa has witnessed significant shifts in the corporate approach toward the advancement of psychedelic services. Investors worldwide are progressively directing their focus toward the potential benefits of venturing into this financial arena.

Many investors however lack the experience and insight to fully comprehend the intricacies of psychedelic clinical care, and the pitfalls, risks, benefits, and expectations involved. In addressing this gap, CAPS stands ready to assist investors with tailored consultation and advice, providing a comprehensive understanding of the landscape and opportunities within the realm of psychedelic services.

Teaching Services

CAPS can provide personalised teaching to individuals, companies, and clinical teams in the following formats

Online teaching e-modules for all aspects of psychedelic pharmacology, clinical interventions, safety, and delivery of services.
Face-to-face lectures.
Half-Day, One-Day, Two-Day or Three-Day workshops for teams.